According to Allogene Therapeutics
's latest financial reports and stock price the company's current price-to-sales ratio (TTM) is 0.8455. At the end of 2024 the company had a P/S ratio of N/A.
P/S ratio history for Allogene Therapeutics
from 2019 to 2024